E for L Aim Public Company Limited (EFORL) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of E for L Aim Public Company Limited THB 0.21, price THB 0.12, upside +75.0%, quality 60 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Fair value above price? Yes
- Good quality? Yes
- Add to watchlist
E for L Aim Public Company Limited
EFORL · BKClearly undervaluedStrong Fair Value upside, but quality is only moderate.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range 0.0800 THB – 2.80 THB · fair‑value band 0.1500 THB – 0.2800 THB · the 0.1200 THB price screens below the 0.2100 THB fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Every Wednesday you see whether E for L Aim Public Company is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
E for L Aim Public Company Limited, together with its subsidiaries, engages in the distribution of medical devices and equipment in Thailand, the United States, Europe, and Asia.
Show more
E for L Aim Public Company Limited, together with its subsidiaries, engages in the distribution of medical devices and equipment in Thailand, the United States, Europe, and Asia. The company offers medical devices, including patient and central monitor systems, defibrillator, automated external defibrillator, electrocardiographs, electroencephalogram, PSG system, and accessories and consumables, as well as ICU, transport, and MRI ventilators, anesthesia delivery system, incubator and radiant warmer, phototherapy, spirometer, pulmonary function lab, and cardiopulmonary exercise testing devices. It also provides handheld and ultrasound scanners, high flow oxygen therapy, ceiling pendant, hemodialysis machine, continuous renal replacement therapy, ozone hybrid, patients and medical devices tracking system, MRI infusion and monitor systems, MRI ferrous metal detector, video laryngoscope, hydrogen peroxide plasma sterilizing, and picture archiving and communication devices, as well as clean rooms, anesthesia record system, ECG viewer system, CIS for hemodialysis, telemedicine, telehealth, and PM and after-sale services. In addition, the company offers diagnosis and laboratory products, such as clinical chemistry, hematology, and immunoassay systems, blood gas and banking, urinalysis, hemoglobin A1C analyzer, automated immunoassay analyzer, rapid test kit, coagulation, POCT clinical chemistry analyzers, air purifier, and laboratory information system. Further, it distributes microscopes for life sciences comprising educational microscopes, clinical and laboratory microscopes, and microscopes for biological scientific research. The company was formerly known as Absolute Impact Public Company Limited and changed its name to E for L Aim Public Company Limited in September 2013. E for L Aim Public Company Limited was incorporated in 2005 and is based in Bangkok, Thailand.
Stock analysis
E for L Aim Public Company Limited (EFORL) currently trades at 0.1200 THB, while our model-based Fair Value estimate is 0.2100 THB, implying the stock looks roughly 42.9% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 0.4000 THB per share, and 21 of the 24 models we run sit above the 0.1200 THB price.
Bear case: the Asset-Based group reads lowest at 0.1000 THB, and 3 of the 24 models stay below the price. Evidence for this calculation is low.
Scenario range: 0.1500 THB (bear) to 0.2800 THB (bull), the price of 0.1200 THB sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 60/100 (solid quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
E for L Aim Public Company Limited reported revenue of 1.3B THB in FY2025 versus 2.2B THB in FY2021, a compound −11.9%/yr. Reported net income was 44.6M THB in FY2025, compounding −51.6%/yr from FY2021.
Key figures
Market cap 520M THB (≈ $15.5M) · P/E ratio 12.0 · P/S ratio 0.41 · EPS (TTM) 0.0100 THB · Net margin 3.4% · Return on equity 8.9% · Return on assets (EBIT) 6.8% · Operating margin 1.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 46 out of 100 (low confidence).
What moves the price
The share trades about 37% below its 52-week high and 20% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 35% fair-value upside, at 75%, EFORL screens cheaper than that median.
Fair Value models
All 24 models by family
Notify me when EFORL reaches fair value
Put EFORL on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Quality Score breakdown
Of which business quality 59 · Market factors (momentum, volatility) 26
Revenue & earnings trend
Growth Forecast
Watch EFORL, get fair value alerts →
Compare E for L Aim Public Company Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Distribution · 83 stocks
Valuation Multiplesvs Medical Distribution median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Valuation of the Thailand market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Distribution stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| McKesson Corporation MCK | $880.50 | $819.31 | −7% |
| Cencora, Inc COR | $312.28 | $211.07 | −32% |
| Cardinal Health, Inc CAH | $221.27 | $141.77 | −36% |
| Henry Schein, Inc HSIC | $87.43 | $76.86 | −12% |
| Shanghai Pharmaceuticals Holding 601607 | ¥16.06 | ¥42.67 | +166% |
| Sinopharm Group 1099 | HK$15.06 | HK$58.89 | +291% |
| Galenica AG GALE | CHF 83.45 | CHF 61.79 | −26% |
| Guangzhou Baiyunshan Pharmaceutical Holdings 600332 | ¥19.67 | ¥26.64 | +35% |
| Jointown Pharmaceutical Group 600998 | ¥4.89 | ¥9.84 | +101% |
| China National Medicines Corporation 600511 | ¥26.11 | ¥58.47 | +124% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is E for L Aim Public Company Limited (EFORL) overvalued or undervalued?
What is the fair value of EFORL?
What is the quality score of EFORL?
What is the price target for E for L Aim Public Company Limited (EFORL)?
What is the E for L Aim Public Company Limited stock forecast for 2026?
What is the revenue of E for L Aim Public Company Limited (EFORL)?
What growth is priced into E for L Aim Public Company Limited (EFORL)?
What discount rate (WACC) does the fair value of EFORL use?
What is a reverse DCF?
How much growth has E for L Aim Public Company Limited (EFORL) delivered so far?
How fast is the sector of E for L Aim Public Company Limited (EFORL) growing?
What is the free cash flow yield of E for L Aim Public Company Limited (EFORL)?
What is the intrinsic value of E for L Aim Public Company Limited (EFORL)?
Is E for L Aim Public Company Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of EFORL?
How much is E for L Aim Public Company Limited worth?
What do the bullish and bearish scenarios say about EFORL?
What is the P/E ratio of EFORL?
How solid is the balance sheet of E for L Aim Public Company Limited (EFORL)?
How far is EFORL from its 52-week high?
Which stocks are comparable to E for L Aim Public Company Limited?
Is E for L Aim Public Company Limited stock attractive at the current price?
How is the fair value of EFORL calculated?
Is it still worth investing in stocks now?
What is the share price of E for L Aim Public Company Limited (EFORL)?
What should I pay attention to with E for L Aim Public Company Limited right now?
Where does the earnings growth of E for L Aim Public Company Limited (EFORL) come from?
Key figures of E for L Aim Public Company Limited
How large is the market capitalisation of E for L Aim Public Company Limited (EFORL)?
What is the P/S ratio of E for L Aim Public Company Limited (EFORL)?
What are the earnings per share of E for L Aim Public Company Limited (EFORL)?
What is the net margin of E for L Aim Public Company Limited (EFORL)?
What is the return on equity of E for L Aim Public Company Limited (EFORL)?
What is the EBIT return on assets of E for L Aim Public Company Limited (EFORL)?
What is the operating margin of E for L Aim Public Company Limited (EFORL)?
How fast is revenue growing at E for L Aim Public Company Limited (EFORL)?
How fast are earnings growing at E for L Aim Public Company Limited (EFORL)?
How much net debt does E for L Aim Public Company Limited (EFORL) carry?
Watch E for L Aim Public Company Limited in the live analysis
One click puts E for L Aim Public Company Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.